What happened
Belgian healthtech startup IntelliProve has closed a €2.7 million seed round led by Miles Ahead, TNW | Health-tech reported. Other participants included Wit-Gele Kruis, a home nursing organisation, along with the imec.istart Fund and several angel investors. The Ghent-based company wants to extend its camera-based health scan beyond virtual care apps and into humanoid robots.
Its software estimates blood pressure, breathing, heart rate and heart rate variability from a 30-second facial scan, using an ordinary camera instead of a cuff. IntelliProve said it has customers in over 50 countries, including insurers, care providers and wellbeing platforms. Co-CEO Joeri Tulkens said about a third of the funding will go to regulatory work, a third to research and the rest to commercial growth, including robotics deployments.
IntelliProve said it is already collaborating with a number of robotics partners, though it declined to name them. Under its plan, a robot would run the scan with its built-in cameras and pass the readings to a person who decides on next steps. The money will also fund more data across skin tones, ages, lighting conditions and devices, plus certification outside Europe. CTO and co-founder Tanguy Sanglet said the standard for the scan is the same on a smartphone or a robot.
Context
IntelliProve's core signal acquisition engine holds a Class I CE mark under EU medical device rules, and the company is pursuing Class IIa. The method, remote photoplethysmography, detects faint skin colour shifts with each heartbeat. IntelliProve reports validating its models on over 6 million data points, with internal tests putting 97.6% of heart rate measurements no more than five beats per minute away from a reference device.
الموجز
أسبوع التقنية في رسالة واحدة.
التقارير التي تستحق وقتك، كل أسبوع. يمكنك إلغاء الاشتراك في أي وقت.
